Related references
Note: Only part of the references are listed.Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Kristian Reich et al.
LANCET (2021)
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials
Emma Guttman-Yassky et al.
LANCET (2021)
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Andrew Blauvelt et al.
JAMA DERMATOLOGY (2021)
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
David M. Pariser et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
Eric Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Japanese guidelines for atopic dermatitis 2020
Norito Katoh et al.
ALLERGOLOGY INTERNATIONAL (2020)
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Sandra Ferreira et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis
G. Yosipovitch et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
Michael D. Howell et al.
FRONTIERS IN IMMUNOLOGY (2019)
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
Eric Simpson et al.
BMC DERMATOLOGY (2019)
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
Iain B. McInnes et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Atopic dermatitis
Stephan Weidinger et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Patrick M. Brunner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Janus kinase inhibitors display broad anti-itch properties: A possible link through the TRPV1 receptor
Tomoki Fukuyama et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis
Zhaohui Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation
N. Gahr et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
JAK Pathway Induction of c-Myc Critical to IL-5 Stimulation of Cell Proliferation and Inhibition of Apoptosis
Wei-Hwa Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
IL-4-/- mice with lethal Mesocestoides corti infections - reduced Th2 cytokines and alternatively activated macrophages
A. E. O'Connell et al.
PARASITE IMMUNOLOGY (2009)
The burden of atopic dermatitis: Impact on the patient, family, and society
CL Carroll et al.
PEDIATRIC DERMATOLOGY (2005)
Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells
H Fujita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
JM Hanifin et al.
EXPERIMENTAL DERMATOLOGY (2001)
Share Paper
